InvestorsHub Logo
Followers 38
Posts 9506
Boards Moderated 0
Alias Born 05/12/2006

Re: Turner2017 post# 281726

Saturday, 11/07/2020 11:46:10 PM

Saturday, November 07, 2020 11:46:10 PM

Post# of 458488
I agree...wow! That was really difficult for me to write...but it felt good.

"The ANAVEX®2-73 (blarcamesine) U.S. Phase 2 study enrolled 31 patients with Rett syndrome and all patients completed the 7-week trial."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News